Biotechnology News

December 9, 2012

ATLANTA--(BUSINESS WIRE)--Millennium and Takeda Report Data from Phase I Trial of ADCETRIS® (Brentuximab Vedotin) in Front-line Mature T-Cell Lymphomas (MTCL)

December 9, 2012

ATLANTA--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today summarized ADCETRIS (brentuximab vedotin) and CD30 expression data in non-Hodgkin lymphomas and other malignancies from multiple presentations at the 54th American Society of...

December 9, 2012

ATLANTA, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced twelve-month follow-up data from the pivotal PACE trial of ponatinib, its investigational BCR-ABL inhibitor, in heavily pretreated...

December 9, 2012

ATLANTA--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today reported data from a phase 1 / 2 study of once a week investigational MLN9708 in combination with...

December 8, 2012

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the Neuromodulation Appropriateness Consensus...

December 8, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced the results of the Phase 3 AMPLIFY-EXT trial, which evaluated treatment with ELIQUIS® (apixaban) over a one-year...

December 8, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of...

December 8, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Final data from Celldex’s Therapeutics CDX-011 Phase 2 study in metastatic breast cancer supports overall survival benefit in patients with high GPNMB-expression; data presented at SABCS.

December 7, 2012

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology presents positive PB272 (neratinib) Phase II clinical data at the 2012 San Antonio Breast Cancer Symposium

December 7, 2012

SAN ANTONIO, Texas--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta® (pertuzumab),...

December 7, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) reported today that an equity award was made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee, Richard Galvez, was...

December 7, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--“Canada's biotech industry is at the core of economic growth and transformation for a vast array of agriculture technologies bringing new value from farm gates,” commented Andrew Casey

December 7, 2012

PORTLAND, Ore.--(BUSINESS WIRE)--CytoDyn expands online presence with video series highlighting the company’s recent accomplishments and future initiatives, including an Arabic-language website to reach its international audience.

December 7, 2012

FRISCO, Texas--(BUSINESS WIRE)--Greatbatch, Inc (NYSE:GB), today announced it has promoted Susan M. Bratton to the position of president of its subsidiary Electrochem Solutions, Inc. Mrs. Bratton previously held the position of senior vice...

December 7, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex CEO Anthony Marucci to present at Oppenheimer 23rd Annual Healthcare Conference on Wednesday, December 12, 2012 at 10:00 am ET; presentation will be webcast.

December 7, 2012

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Proactive Worldwide, Inc. (PWW), a leader in providing customized business intelligence research and consulting services, announces today that Dennis Timko has joined the company as Engagement Manager for the...

December 7, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Announces Pricing of a Public Offering of Common Stock and Warrants

December 7, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) to Present Eleven Oral or Poster Sessions at the 54th Annual American Society of Hematology Meeting

December 7, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASI is collaborating with DSI to conduct a first-of-its-kind study combining BASi's Culex®-L automated sampling system with DSI's newest large animal telemetry technology, PhysioTel™ Digital.

December 7, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its first fiscal quarter of...

December 7, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Highlights 19 Abstracts at the 54th Annual Meeting of the American Society of Hematology

December 7, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Thyrogen has received European Commission approval of a product label expansion for the use of with a wider irradiation dose range for postoperative thyroid remnant ablation.

December 7, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today that in response to recent events and an assessment of its assets, the Company is restructuring and implementing a focused strategy to...

December 7, 2012

SINGAPORE--(BUSINESS WIRE)--Invida Holdings Private Limited, the leading biopharmaceutical commercialization company in Asia-Pacific, is pleased to announce a name change to A. Menarini Asia-Pacific Holdings Pte. Ltd. (“Menarini Asia-Pacific”)...

December 7, 2012

DENVER--(BUSINESS WIRE)--The Colorado BioScience Association (CBSA) is honoring the outstanding bioscience companies and individuals in the state during its Annual Awards Dinner at the Hyatt Convention Center, Denver.

December 6, 2012

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation Announces Proposed Public Offering of Common Stock and Warrants

December 6, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company’s Phase 3 antibiotic candidates, CXA-201 (ceftolozane/tazobactam)...

December 6, 2012

MIDLAND, Mich.--(BUSINESS WIRE)--When Impact Analytical opens the doors to its new home early next year, it will signal two things – that it’s a company on the grow, and that it doesn’t expect to stop anytime soon.

December 6, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) today announced that the Company plans to report second quarter fiscal year 2013 financial results on Form 10-Q on Friday, December 14, 2012. Oxygen’s President and...

December 6, 2012

BOSTON--(BUSINESS WIRE)--BioSurplus today celebrates the grand opening of its new 20,000-square-foot showroom and warehouse located at 57 Water Street in Watertown, Mass.

December 6, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The following items were addressed at the Annual General Meeting of Diamyd Medical AB (publ) (STO:DIAM.B)(Pink Sheets:DMYDY) held today: Diamyd Medical's President and CEO Peter Zerhouni gave a...

December 6, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Cardiosonic, Inc., a private company developing innovative and proprietary technology in the field of Renal Denervation for the treatment of Hypertension, announced today that it has closed on the first $6.1...

December 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that bisphosphonates will continue to dominate current and future prescriptions for...

December 6, 2012

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces that the European Independent Board...

December 6, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Drug companies more likely to cut sales forces or research & development budgets, but regulatory affairs budgets increase, according to Cutting Edge Information.

December 6, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE: ENZ), will hold a conference call to discuss fiscal 2013 first quarter results on Tuesday, December 11, 2012, at 8:30 AM E.T. To listen to the conference call dial 1-888-459-5609. International...

December 6, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the availability of the newest version of its revolutionary Intelligent System Emulation Technology. This new version of ISET allows emulation of the Waters...

December 6, 2012

BERLIN--(BUSINESS WIRE)--NOXXON Pharma announced its participation at the 54th annual meeting of the American Society of Hematology (ASH) in Atlanta, USA from 8-11 December 2012 with two oral presentations and two posters.

December 6, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that in their two latest EU5 reports on rheumatoid arthritis (RA), there have been some...

December 6, 2012

BOSTON--(BUSINESS WIRE)--Sagentia today announced that their United States headquarters has moved from the Cambridge Innovation Center in Cambridge, Mass. to One Beacon Street in Boston.

December 6, 2012

SAN ANTONIO, Texas--(BUSINESS WIRE)--To be presented today at the 34th CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in Texas, USA, the status of the clinical trial to evaluate Reparixin safety and pharmacokinetic profile, administered...

December 6, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using...

December 6, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--RedHill Biopharma Ltd. (TASE:RDHL), an Israeli biopharmaceutical company focusing primarily on development and acquisition of late clinical stage, patent-protected, new formulations and combinations of existing...

December 6, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, across all cancer types, surveyed U.S. oncologists estimate that 69 percent of...

December 6, 2012

CINCINNATI--(BUSINESS WIRE)--Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.

December 6, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced it is initiating development of its lead cancer drug...

December 6, 2012

TORONTO--(BUSINESS WIRE)--First U.S. Patient Implanted in Functional Neuromodulation Study of Deep Brain Stimulation for Alzheimer's.

December 6, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that its Smac mimetic birinapant was presented during an oral session at...